Norway vs United Kingdom of Great Britain and Northern Ireland: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Norway
0.0%
in 2024
United Kingdom of Great Britain and Northern Ireland
0.0%
in 2024
Norway rank
167th
United Kingdom of Great Britain and Northern Ireland rank
167th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Norway
- United Kingdom of Great Britain and Northern Ireland
How they compare
Norway currently reports 0.0% against 0.0% in United Kingdom of Great Britain and Northern Ireland, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was United Kingdom of Great Britain and Northern Ireland ahead.
Norway ranks 167th and United Kingdom of Great Britain and Northern Ireland ranks 167th of 246 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Norway | United Kingdom of Great Britain and Northern Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | Norway |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Norway or United Kingdom of Great Britain and Northern Ireland?
- Norway, at 0.0% against 0.0% in United Kingdom of Great Britain and Northern Ireland as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Norway and United Kingdom of Great Britain and Northern Ireland?
- 0.0%, with Norway ahead.
- How many years of comparable data are there for Norway and United Kingdom of Great Britain and Northern Ireland?
- 10 years are reported by both, from 2015 to 2024.
- How do Norway and United Kingdom of Great Britain and Northern Ireland rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Norway ranks 167th and United Kingdom of Great Britain and Northern Ireland ranks 167th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.